CORDIS · 101007653 · H2020
CANLEISH Non-invasive volatiles test for canine leishmaniasis diagnosis
Coordinator: UNIVERSITATEA SPIRU HARET (RO)
Canine leishmaniasis is among the most important vector-borne parasitic diseases of dogs. This study will focus on investigating the feasibility of a non-invasive methodology for the diagnosis of canine leishmaniasis in dogs via the analysis of non-invasive volatile samples emitted by dogs’ breath and hair, employing analytical methods and a system composed of different chemical gas sensing devices.
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €1.9M awarded to the consortium. The project runs over approximately 4 years from 2021-05-01 to 2025-04-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from RO
see all →- CARMINE — Climate-Resilient Development Pathways in Metropolitan Regions of Europe101137851 · HORIZON · €10.2M
- CVDLINK — A federated paradigm of real-world data sources utilization for the empowerment of diagnosis, prognosis and risk assessment of cardiovascular conditions101137278 · HORIZON · €9.7M
- DOORS — Developing Optimal and Open Research Support for the Black Sea (DOORS)101000518 · H2020 · €9.0M
- EUTOPIA_HEALTH — Empowering Widening universities in EUTOPIA_HEALTH consortium to foster academic excellence in Health101136914 · HORIZON · €5.0M
- UNICORE — A Common Code Base and Toolkit for Deployment of Applications to Secure and Reliable Virtual Execution Environments825377 · H2020 · €4.3M
- OptFor-EU — OPTimising FORest management decisions for a low-carbon, climate resilient future in EUrope101060554 · HORIZON · €4.3M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the MSCA-RISE funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.9M toward a total project budget of €1.9M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call H2020-MSCA-RISE-2020.
- Who coordinates the project?
- The project is coordinated by UNIVERSITATEA SPIRU HARET (RO).
- What is the project timeline?
- The project runs from 2021-05-01 to 2025-04-30 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101007653.